Friday 8 February | |
SSE | Trading Statement |
Shaftesbury | Trading Statement |
Monday 11 February | |
Acacia Mining | Full Year Results |
Lok'n Store | Trading Statement |
UP Global Sourcing | Trading Statement |
Tuesday 12 February | |
TUI | Q1 Results |
A&J Mucklow | Half Year Results |
Loop Up Group | Trading Statement |
AA | Trading Statement |
Plus500 | Full Year Results |
Wednesday 13 February | |
Smurfit Kappa | Full Year Results |
Tullow Oil | Full Year Results |
RWS Holdings | Trading Statement |
BB Healthcare Trust | Full Year Results |
Time Out | Trading Statement |
Galliford Try | Half Year Results |
Dunelm Group | Half Year Results |
Thursday 14 February | |
Coca-Cola HBC | Full Year Results |
Micro Focus International | Full Year Results |
Convatec | Full Year Results |
Indivior | Full Year Results |
MJ Gleeson | Half Year Results |
Safestore Holdings | Q1 Results |
AstraZeneca | Full Year Results |
Ashmore Group | Half Year Results |
Lancashire Holdings | Full Year Results |
Trifast | Trading Statement |
Moneysupermarket.com | Full Year Results |
UK Commercial Property REIT | Trading Statement |
![ShareCast](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
Indivior unable to provide guidance amid Suboxone uncertainty
(Sharecast News) - Indivior said it was unable to give investors an indication of revenue and profit for the current year due to uncertainty about how its star drug will affect by copycat versions.
Read more